GUARALDI, Giovanni
GUARALDI, Giovanni
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
"Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients
2008 C., Stentarelli; S., Zona; V., Rochira; G., Caffagni; L., Zirilli; S., Ballestri; A., Lonardo; D'Amico, Roberto; N., Squillace; G., Orlando; P., Loria; Guaraldi, Giovanni
"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression
2019 Guaraldi, Giovanni; Arends, Joop; Buhk, Thomas; Cascio, Mario; Curran, Adrian; Teofilo, Eugenio; Berk, Guido Van Den; Verger, Christian
"Moving Fourth": Introduction of a practical toolkit for shared decision-making to facilitate healthy living beyond HIV viral suppression
2021 Curran, Adrian; Arends, Joop; Buhk, Thomas; Cascio, Mario; Teofilo, Eugenio; van den Berk, Guido; Guaraldi, Giovanni
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies
2007 Dominici, Massimo; Sternieri, R.; De Fazio, D.; Cafarelli, L.; Guaraldi, Giovanni; Spano, C.; Rasini, V.; Paolucci, P.; Cilli, M.; Piccardi, F.; Astori, G.; Hofmann, T. J.; Horwitz, E.; Conte, P. F.
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients
2020 Guaraldi, G.; Milic, J.; Prandini, N.; Ligabue, G.; Esposito, F.; Ciusa, G.; Malagoli, A.; Scaglioni, R.; Besutti, G.; Beghetto, B.; Nardini, G.; Roncaglia, E.; Mussini, C.; Raggi, P.
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0
2020 Ryom, L; Cotter, A; De Miguel, R; Béguelin, C; Podlekareva, D; Arribas, J R; Marzolini, C; Mallon, Pgm; Rauch, A; Kirk, O; Molina, J M; Guaraldi, G; Winston, A; Bhagani, S; Cinque, P; Kowalska, J D; Collins, S; Battegay, M
A call for health systems to monitor the health-related quality of life of people living with HIV
2023 Lazarus, Jeffrey V; Van Hout, Marie Claire; Fuster-Ruizdeapodaca, Maria J; Brown, Graham; Guaraldi, Giovanni
A case of primery progressive multiple sclerosis like illness in HIV infection: one or two different diseases?
2003 Casoni, F.; Guaraldi, Giovanni; Cortelli, P.; Merelli, E.
A comprehensive development agenda on tenofovir alafenamide in clinical practice
2018 Di Biagio, A; Riccardi, N; Rusconi, S; Guaraldi, G; Borderi, M; De Luca, A; Gianotti, N; Lo Caputo, S; Maggi, P; Maserati, R; Maggiolo, F
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients
2017 Guaraldi, Giovanni; Dolci, Giovanni; Zona, Stefano; Tarantino, Giuseppe; Serra, Valentina; Ballarin, Roberto; Franceschini, Erica; Codeluppi, Mauro; Brothers, Thomas D.; Mussini, Cristina; Di Benedetto, Fabrizio
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
2015 Guaraldi, Giovanni; Brothers, Thomas D.; Zona, Stefano; Stentarelli, Chiara; Carli, Federica; Malagoli, Andrea; Santoro, Antonella; Menozzi, Marianna; Mussi, Chiara; Mussini, Cristina; Kirkland, Susan; Falutz, Julian; Rockwood, Kenneth
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV
2023 Motta, F.; Milic, J.; Gozzi, L.; Belli, M.; Sighinolfi, L.; Cuomo, G.; Carli, F.; Dolci, G.; Iadisernia, V.; Burastero, G.; Mussini, C.; Missier, P.; Mandreoli, F.; Guaraldi, G.
A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus
2025 Guaraldi, Giovanni; Milic, Jovana
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV
2020 Guaraldi, Giovanni; Milic, Jovana; Marcotullio, Simone; Mussini, Cristina
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
2008 Guaraldi, Giovanni; Cocchi, Stefania; A., Motta; S., Ciaffi; M., Codeluppi; S., Bonora; Di Benedetto, Fabrizio; M., Masetti; M., Floridia; S., Baroncelli; D., Pinetti; A., D'Avolio; A., Bertolini; Esposito, Roberto
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
2022 Alteri, Claudia; Fox, Valeria; Scutari, Rossana; Burastero, Giulia Jole; Volpi, Sara; Faltoni, Matteo; Fini, Vanessa; Granaglia, Annarita; Esperti, Sara; Gallerani, Altea; Costabile, Valentino; Fontana, Beatrice; Franceschini, Erica; Meschiari, Marianna; Campana, Andrea; Bernardi, Stefania; Villani, Alberto; Bernaschi, Paola; Russo, Cristina; Guaraldi, Giovanni; Mussini, Cristina; Perno, Carlo Federico
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy.
2011 Guaraldi, Giovanni; Zona, Stefano; Cossarizza, Andrea; L., Vernacotola; Carli, Federica; A., Lattanzi; Beghetto, Barbara; Orlando, Gabriella; R., Termini; M., Garau
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz
2012 L., Albini; B. M., Cesana; D., Motta; E., Focà; D., Gotti; A., Calabresi; I., Izzo; R., Bellagamba; R., Fezza; P., Narciso; L., Sighinolfi; P., Maggi; E., Quiros Roldan; L., Manili; Guaraldi, Giovanni; G., Lapadula; C., Torti
A rare case of localized mucosal leishmaniasis due to Leishmania infantum in an immunocompetent Italian host
2005 Casolari, Chiara; Guaraldi, Giovanni; M., Pecorari; G., Tamassia; C., Cappi; Fabio, Giuliana; A. M., Cesinaro; R., Piolini; F., Rumpianesi; Presutti, Livio
Abacavir and Tenofovir impact on endothelial.
2012 Guaraldi, Giovanni; Zona, Stefano; Roverato, A; Orlando, Gabriella; Carli, Federica; Lattanzi, A; Manzini, L; Bisi, L; Cicognani, A; Rossi, Rosario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients | 1-gen-2008 | C., Stentarelli; S., Zona; V., Rochira; G., Caffagni; L., Zirilli; S., Ballestri; A., Lonardo; D'Amico, Roberto; N., Squillace; G., Orlando; P., Loria; Guaraldi, Giovanni | |
| "Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression | 1-gen-2019 | Guaraldi, Giovanni; Arends, Joop; Buhk, Thomas; Cascio, Mario; Curran, Adrian; Teofilo, Eugenio; Berk, Guido Van Den; Verger, Christian | |
| "Moving Fourth": Introduction of a practical toolkit for shared decision-making to facilitate healthy living beyond HIV viral suppression | 1-gen-2021 | Curran, Adrian; Arends, Joop; Buhk, Thomas; Cascio, Mario; Teofilo, Eugenio; van den Berk, Guido; Guaraldi, Giovanni | |
| 0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies | 1-gen-2007 | Dominici, Massimo; Sternieri, R.; De Fazio, D.; Cafarelli, L.; Guaraldi, Giovanni; Spano, C.; Rasini, V.; Paolucci, P.; Cilli, M.; Piccardi, F.; Astori, G.; Hofmann, T. J.; Horwitz, E.; Conte, P. F. | |
| 18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients | 1-gen-2020 | Guaraldi, G.; Milic, J.; Prandini, N.; Ligabue, G.; Esposito, F.; Ciusa, G.; Malagoli, A.; Scaglioni, R.; Besutti, G.; Beghetto, B.; Nardini, G.; Roncaglia, E.; Mussini, C.; Raggi, P. | |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 | 1-gen-2020 | Ryom, L; Cotter, A; De Miguel, R; Béguelin, C; Podlekareva, D; Arribas, J R; Marzolini, C; Mallon, Pgm; Rauch, A; Kirk, O; Molina, J M; Guaraldi, G; Winston, A; Bhagani, S; Cinque, P; Kowalska, J D; Collins, S; Battegay, M | |
| A call for health systems to monitor the health-related quality of life of people living with HIV | 1-gen-2023 | Lazarus, Jeffrey V; Van Hout, Marie Claire; Fuster-Ruizdeapodaca, Maria J; Brown, Graham; Guaraldi, Giovanni | |
| A case of primery progressive multiple sclerosis like illness in HIV infection: one or two different diseases? | 1-gen-2003 | Casoni, F.; Guaraldi, Giovanni; Cortelli, P.; Merelli, E. | |
| A comprehensive development agenda on tenofovir alafenamide in clinical practice | 1-gen-2018 | Di Biagio, A; Riccardi, N; Rusconi, S; Guaraldi, G; Borderi, M; De Luca, A; Gianotti, N; Lo Caputo, S; Maggi, P; Maserati, R; Maggiolo, F | |
| A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients | 1-gen-2017 | Guaraldi, Giovanni; Dolci, Giovanni; Zona, Stefano; Tarantino, Giuseppe; Serra, Valentina; Ballarin, Roberto; Franceschini, Erica; Codeluppi, Mauro; Brothers, Thomas D.; Mussini, Cristina; Di Benedetto, Fabrizio | |
| A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity | 1-gen-2015 | Guaraldi, Giovanni; Brothers, Thomas D.; Zona, Stefano; Stentarelli, Chiara; Carli, Federica; Malagoli, Andrea; Santoro, Antonella; Menozzi, Marianna; Mussi, Chiara; Mussini, Cristina; Kirkland, Susan; Falutz, Julian; Rockwood, Kenneth | |
| A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV | 1-gen-2023 | Motta, F.; Milic, J.; Gozzi, L.; Belli, M.; Sighinolfi, L.; Cuomo, G.; Carli, F.; Dolci, G.; Iadisernia, V.; Burastero, G.; Mussini, C.; Missier, P.; Mandreoli, F.; Guaraldi, G. | |
| A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus | 1-gen-2025 | Guaraldi, Giovanni; Milic, Jovana | |
| A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV | 1-gen-2020 | Guaraldi, Giovanni; Milic, Jovana; Marcotullio, Simone; Mussini, Cristina | |
| A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. | 1-gen-2008 | Guaraldi, Giovanni; Cocchi, Stefania; A., Motta; S., Ciaffi; M., Codeluppi; S., Bonora; Di Benedetto, Fabrizio; M., Masetti; M., Floridia; S., Baroncelli; D., Pinetti; A., D'Avolio; A., Bertolini; Esposito, Roberto | |
| A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients | 1-gen-2022 | Alteri, Claudia; Fox, Valeria; Scutari, Rossana; Burastero, Giulia Jole; Volpi, Sara; Faltoni, Matteo; Fini, Vanessa; Granaglia, Annarita; Esperti, Sara; Gallerani, Altea; Costabile, Valentino; Fontana, Beatrice; Franceschini, Erica; Meschiari, Marianna; Campana, Andrea; Bernardi, Stefania; Villani, Alberto; Bernaschi, Paola; Russo, Cristina; Guaraldi, Giovanni; Mussini, Cristina; Perno, Carlo Federico | |
| A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. | 1-gen-2011 | Guaraldi, Giovanni; Zona, Stefano; Cossarizza, Andrea; L., Vernacotola; Carli, Federica; A., Lattanzi; Beghetto, Barbara; Orlando, Gabriella; R., Termini; M., Garau | |
| A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz | 1-gen-2012 | L., Albini; B. M., Cesana; D., Motta; E., Focà; D., Gotti; A., Calabresi; I., Izzo; R., Bellagamba; R., Fezza; P., Narciso; L., Sighinolfi; P., Maggi; E., Quiros Roldan; L., Manili; Guaraldi, Giovanni; G., Lapadula; C., Torti | |
| A rare case of localized mucosal leishmaniasis due to Leishmania infantum in an immunocompetent Italian host | 1-gen-2005 | Casolari, Chiara; Guaraldi, Giovanni; M., Pecorari; G., Tamassia; C., Cappi; Fabio, Giuliana; A. M., Cesinaro; R., Piolini; F., Rumpianesi; Presutti, Livio | |
| Abacavir and Tenofovir impact on endothelial. | 1-gen-2012 | Guaraldi, Giovanni; Zona, Stefano; Roverato, A; Orlando, Gabriella; Carli, Federica; Lattanzi, A; Manzini, L; Bisi, L; Cicognani, A; Rossi, Rosario |
